Insider Selling: Ronald L. Meeusen Unloads 500,000 Shares of Aratana Therapeutics Stock (PETX)
Aratana Therapeutics (NASDAQ:PETX) Director Ronald L. Meeusen sold 500,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $19.00, for a total transaction of $9,500,000.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of Aratana Therapeutics (NASDAQ:PETX) traded up 2.76% on Wednesday, hitting $21.25. 200,042 shares of the company’s stock traded hands. Aratana Therapeutics has a 52 week low of $6.56 and a 52 week high of $29.32. The stock has a 50-day moving average of $18.92 and a 200-day moving average of $16.71. The company’s market cap is $498.2 million.
Aratana Therapeutics (NASDAQ:PETX) last posted its quarterly earnings results on Wednesday, November 13th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.02. Analysts expect that Aratana Therapeutics will post $-7.48 EPS for the current fiscal year.
Aratana Therapeutics, Inc is a development-stage biopharmaceutical company. As of March 20, 2013, the Company has three licensed compounds in development for six product approvals in cats and dogs in each of the United States and Europe.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.